LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Headache with SARS-CoV-2 infection: A matter of concern.

    Dearing, Lukas / Müller, Felix / Sellner, Johann

    European journal of neurology

    2021  Volume 28, Issue 11, Page(s) 3554–3555

    MeSH term(s) COVID-19 ; Headache/etiology ; Humans ; SARS-CoV-2
    Language English
    Publishing date 2021-09-03
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.15084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Headache in COVID-19 and Long COVID: to Know Facts for Clinical Practice.

    Gómez-Dabó, Laura / Melgarejo-Martínez, Laura / Caronna, Edoardo / Pozo-Rosich, Patricia

    Current neurology and neuroscience reports

    2023  Volume 23, Issue 10, Page(s) 551–560

    Abstract: ... from headaches and the potential risk of worsening in the setting of SARS-CoV-2 infection. Although there is ... on the characteristics of headache in COVID-19 caused by the new SARS-CoV-2 (Omicron) variants and how ... of the pandemic, making COVID-19 headache still a challenging matter for clinicians. New research is ...

    Abstract Purpose of review: Headache is one of the most frequent symptoms of the acute and post-acute phase of COVID-19. Specific epidemiology, clinical features, risk factors, pathophysiology, and treatment have been reported in these two scenarios. With this narrative review of the literature, we aim to provide updated knowledge on headache in the COVID-19 setting and give clinicians a practical approach on this topic to guide them in their clinical practice.
    Recent findings: Headache mechanisms in COVID-19 are still poorly understood. Strong evidence is also lacking on how to best treat and manage these patients, especially those with persistent and disabling headache after COVID-19. Data are also scarce on the characteristics of headache in COVID-19 caused by the new SARS-CoV-2 (Omicron) variants and how these may influence the acute and persistent symptoms of COVID-19. Patients with pre-existing primary headache disorders remain a particularly concerning population due to their biological predisposition in suffering from headaches and the potential risk of worsening in the setting of SARS-CoV-2 infection. Although there is an exponential growth of scientific evidence, studies are often controversial and focused on the first wave of the pandemic, making COVID-19 headache still a challenging matter for clinicians. New research is therefore needed.
    Language English
    Publishing date 2023-09-04
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057363-7
    ISSN 1534-6293 ; 1528-4042
    ISSN (online) 1534-6293
    ISSN 1528-4042
    DOI 10.1007/s11910-023-01296-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top